Natixis Investment Managers International’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
SOMRS
KA
Natixis Investment Managers International's TDOC Position: Q4 2022 in Review
Natixis Investment Managers International sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 1,069 shares — an estimated $27K sold.
Natixis Investment Managers International first reported a position in TDOC in Q4 2020 and held it in 8 quarters. The position peaked at $216K in Q1 2022. 445 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.
- Natixis Investment Managers International reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
- Natixis Investment Managers International sold 1,069 Teladoc Health shares in Q4 2022, an estimated $27K.
- Natixis Investment Managers International first reported a position in Teladoc Health in Q4 2020 and held it in 8 quarters.
- Natixis Investment Managers International's Teladoc Health position peaked at $216K in Q1 2022.
- 445 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.
Based on Natixis Investment Managers International's 13F filing for Q4 2022, filed 13 Feb 2023.